Načítá se...
Sulfasalazine decreases mouse cortical hyperexcitability
OBJECTIVE: Currently prescribed antiepileptic drugs (AEDs) are ineffective in treating approximately 30% of epilepsy patients. Sulfasalazine (SAS) is an US Food and Drug Administration (FDA)–approved drug for the treatment of Crohn disease that has been shown to inhibit the cystine/glutamate antipor...
Uloženo v:
| Vydáno v: | Epilepsia |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6771750/ https://ncbi.nlm.nih.gov/pubmed/31211419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/epi.16073 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|